Clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer.

Sectors
Healthcare
Life Sciences
First Invested
2016
Public/PIPES
Company Status
IPO/Acquired
NASDAQ: CASC
Acquired by Seattle Genetics
Associated Team
Paul Walker